Patents by Inventor Michel Poncet

Michel Poncet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Inflammatory Lesions of Rosacea with Ivermectin
    Publication number: 20220347198
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: July 7, 2022
    Publication date: November 3, 2022
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Nathalie Sordello Wagner, Alexandre Kaoukhov, Michael Graeber, Laurence Salin, Michel Poncet, Philippe Briantais, Khaled Benkali
  • Treatment of Inflammatory Lesions of Rosacea with Ivermectin
    Publication number: 20210177882
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: February 18, 2021
    Publication date: June 17, 2021
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20200000835
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: August 23, 2019
    Publication date: January 2, 2020
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • Treatment of papulopustular rosacea with ivermectin
    Patent number: 10206939
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: February 19, 2019
    Assignee: Galderma S.A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Alexandre Kaoukhov, Michael Graeber, Michel Poncet, Philippe Briantais, Laurence Salin
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20180264021
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: May 24, 2018
    Publication date: September 20, 2018
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Michel PONCET, Philippe BRIANTAIS, Laurence SALIN
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20180207188
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: March 1, 2018
    Publication date: July 26, 2018
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Michel PONCET, Philippe BRIANTAIS, Laurence SALIN
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20180177813
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: February 22, 2018
    Publication date: June 28, 2018
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • Treatment of papulopustular rosacea with ivermectin
    Patent number: 9782425
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Grant
    Filed: July 8, 2014
    Date of Patent: October 10, 2017
    Assignee: Galderma S.A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Alexandre Kaoukhov, Michael Graeber, Laurence Salin, Michel Poncet, Philippe Briantais
  • COMBINATION/ASSOCIATION OF ADAPALENE AND BENZOYL PEROXIDE FOR TREATING ACNE
    Publication number: 20170202803
    Abstract: Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Inventors: Marie-Line Abou Chacra VERNET, Denis GROSS, Christian LOESCHE, Michel PONCET
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20160184342
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: July 8, 2014
    Publication date: June 30, 2016
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20160175337
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: December 17, 2015
    Publication date: June 23, 2016
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Michel PONCET, Philippe BRIANTAIS, Laurence SALIN
  • TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
    Publication number: 20160158263
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Application
    Filed: July 8, 2014
    Publication date: June 9, 2016
    Inventors: Jean JACOVELLA, Jian-Paul CHAPPUIS, Alexandre KAOUKHOV, Michael GRAEBER, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS
  • TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
    Publication number: 20160143935
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Application
    Filed: December 17, 2015
    Publication date: May 26, 2016
    Inventors: Jean JACOVELLA, Jean-Paul CHAPPUIS, Nathalie SORDELLO WAGNER, Michael GRAEBER, Alexandre KAOUKHOV, Laurence SALIN, Michel PONCET, Philippe BRIANTAIS, Khaled BENKALI
  • Treatment of inflammatory lesions of rosacea with ivermectin
    Patent number: 9233117
    Abstract: Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 12, 2016
    Assignee: Galderma S. A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Nathalie Sordello Wagner, Michael Graeber, Alexandre Kaoukhov, Laurence Salin, Michel Poncet, Philippe Briantais, Khaled Benkali
  • Treatment of papulopustular rosacea with ivermectin
    Patent number: 9233118
    Abstract: Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 12, 2016
    Assignee: Galderma S.A.
    Inventors: Jean Jacovella, Jean-Paul Chappuis, Alexandre Kaoukhov, Michael Graeber, Michel Poncet, Philippe Briantais, Laurence Salin
  • COMBINATION/ASSOCIATION OF ADAPALENE AND BENXOYL PEROXIDE FOR TREATING ACNE LESIONS
    Publication number: 20140296340
    Abstract: Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).
    Type: Application
    Filed: June 11, 2014
    Publication date: October 2, 2014
    Inventors: Marie-Line Abou Chacra VERNET, Denis GROSS, Christian LOESCHE, Michel PONCET
  • Combination/association of adapalene and benzoyl peroxide for treating acne lesions
    Patent number: 8785420
    Abstract: Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: July 22, 2014
    Assignee: Galderma Research & Development
    Inventors: Marie-Line Abou Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet
  • COMBINATIONS OF ADAPALENE AND BENZOYL PEROXIDE FOR TREATING ACNE LESIONS
    Publication number: 20140031427
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 30, 2014
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Marie-Line ABOU-CHACRA VERNET, Denis GROSS, Christian LOESCHE, Michel PONCET
  • COMBINATIONS OF ADAPALENE AND BENZOYL PEROXIDE FOR TREATING ACNE LESIONS
    Publication number: 20130253062
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Application
    Filed: May 13, 2013
    Publication date: September 26, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Marie-Line ABOU-CHACRA VERNET, Denis GROSS, Christian LOESCHE, Michel PONCET
  • Combinations of adapalene and benzoyl peroxide for treating acne lesions
    Patent number: 8445543
    Abstract: Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: May 21, 2013
    Assignee: Galderma Research & Development
    Inventors: Marie-line Abou-Chacra Vernet, Denis Gross, Christian Loesche, Michel Poncet